Several factors controlling inflammation and immune response have been identified to play regulatory actions in melanoma, such as Platelet Activating Factor (PAF) [9], microphthalmia-associated transcription factor (MITF) [13], granulocyte-macrophage colony-stimulating factor [14], TNF-alpha [15], transforming growth factor [16]. The gene discussed is MITF; the disease is melanoma.